U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...

The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.

Mylan and Novo Nordisk have reached a confidential settlement over the generic version of Ozempic, with Natco Pharma holding ...

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is ...

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads. Here’s ...

Medicare covers Wegovy as a treatment to reduce the risk of serious cardiovascular events in people who have overweight or obesity. It does not cover Wegovy for weight loss.

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

The United States may have reached a turning point in its decades-long battle against obesity. Recent data suggests that 2020 ...

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads.

Medicare covers Wegovy only as a treatment to reduce the risk of heart attacks and strokes in people who have overweight or obesity. It does not cover Wegovy for weight loss. Medicare is currently ...